BDSX - Company ID 0001439725
The table below shows BIODESIX INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $88.50M | $71.32M | $49.09M | $38.21M | $54.51M | $45.56M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $12.00M | $9.56M | $9.99M | $13.10M | $12.79M | $10.82M |
| SG&A |
BIODESIX INC reported annual revenue of $88.50M for fiscal year 2025. That is up 24.1% from $71.32M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $24.55M (FY 2019) to $88.50M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $87.55M |
| $80.45M |
| $67.39M |
| $61.46M |
| $50.52M |
| $34.86M |
| Operating income | -$27.87M | -$34.50M | -$41.34M | -$50.59M | -$40.94M | -$22.93M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$35.27M | -$42.93M | -$52.15M | -$65.45M | -$43.16M | -$65.45M |
| EPS (diluted) | -$4.67 | -$6.64 | -$0.64 | -$1.55 | -$1.58 | - |